Other
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
Paper Details
Title
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
Published Date
Jan 10, 2019
Journal
Volume
33
Issue
4
Pages
1047 - 1051
Notes
History